Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Non-Current Debt (2018 - 2025)

Inventiva (IVEVF) posted Non-Current Debt of $32.1 million for Q4 2025, down 45.09% on a QoQ basis from $58.4 million in Q2 2025, and down 38.07% year-over-year from $51.8 million in Q4 2024.

Analysis

Inventiva (IVEVF) Non-Current Debt (2018 - 2025) Analysis & Trends

Inventiva has reported Non-Current Debt for 8 years, with the latest figure at $32.1 million in Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 38.07% year-over-year to $32.1 million in Q4 2025; TTM through Dec 2025 was $32.1 million, a 38.07% decrease from a year earlier, with the FY2025 full-year figure at $32.1 million, down 38.07% from the prior year.
  • Non-Current Debt was $32.1 million for Q4 2025 at Inventiva, down from $58.4 million in the prior quarter.
  • The five-year high for Non-Current Debt was $58.4 million in Q2 2025, with the low at $10.1 million in Q4 2021.
  • Average Non-Current Debt over 5 years is $30.8 million, with a median of $32.1 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Debt soared 189.27% in 2022, then tumbled 38.07% in 2025.
  • Over 5 years, Non-Current Debt stood at $10.1 million in 2021, then jumped by 189.27% to $29.2 million in 2022, then climbed by 18.4% to $34.6 million in 2023, then surged by 49.56% to $51.8 million in 2024, then sank by 38.07% to $32.1 million in 2025.
  • The last three Non-Current Debt figures came in at $32.1 million (Q4 2025), $58.4 million (Q2 2025), and $51.8 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 37.34 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 62.48 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn -
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 44.19 Bn 44.19 Bn - -
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn -
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn -
10 Inventiva 693.72 Mn 693.72 Mn - 32.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 32.07 Mn
Jun 30, 2025 58.41 Mn
Dec 31, 2024 51.78 Mn
Jun 30, 2024 50.45 Mn
Dec 31, 2023 34.62 Mn
Jun 30, 2023 33.77 Mn
Dec 31, 2022 29.24 Mn
Jun 30, 2022 14.34 Mn
Dec 31, 2021 10.11 Mn
Jun 30, 2021 12.14 Mn
Mar 31, 2021 12.15 Mn
Dec 31, 2020 11.97 Mn
Dec 31, 2019 2,213.78
Dec 31, 2018 84,463.34